Clinical Trials
Participate. Discover. Advance.
ev3 is committed to be the best in delivering breakthrough clinical data of endovascular technologies that enhances patients’ quality of life. As a leader in the peripheral vascular arena and through innovative collaborative partnerships we are able to deliver relevant data allowing physicians to make evidence-based medical decisions in their day-to-day practice. We recognize the Gift of Participation and are committed to ethical principals to protect the well-being of patient participants.
The DEFINITIVE™ Trial Series
The DEFINITIVE Trial Series is designed to provide robust clinical data to help improve treatment outcomes and facilitate the broader adoption of plaque excision as a frontline tool in the treatment of P.A.D.|
A Peripheral Artery Disease (P.A.D.) study designed to evaluate the SilverHawk® LS-C (RockHawk) and TurboHawk™ Plaque Excision Systems and SpiderFX® Embolic Protection Device in the endovascular treatment of moderate to severely calcified lesions in femoropopliteal arteries.
|
|
DEFINITIVE LE
A Peripheral Artery Disease (P.A.D.) study designed to confirm the value of plaque excision with the SliverHawk® and TurboHawk™ Systems in femoropopliteal and tibial-peroneal arteries. |
|
DEFINITIVE AR
A Peripheral Artery Disease (P.A.D.) study designed to evaluate the safety and efficacy of preparing a vessel with plaque excision prior to treatment with a drug-coated balloon. The study is being conducted outside of the United States with a drug-coated balloon that is an investigational device. |
| CREATE PAS A Carotid Artery study designed to evaluate the PROTÉGÉ® RX Carotid Stent Systems and SpiderFX® Embolic Protection device in the treatment of common and/or internal carotid artery stenoses for subjects with a high risk for complications during endarterectomy. |
| DURABILITY II A Peripheral Artery Disease (P.A.D.) study comparing the PROTÉGÉ® EverFlex™ Self-Expanding Stent to performance goals associated with PTA in SFA and proximal popliteal arteries. |